Lvm-MD-14 (Prea/Pmr/Phase 3/Double-Blind)
Research payments
$168,572
Through program year 2020, $168,572 in research payments was reported against Lvm-MD-14 (Prea/Pmr/Phase 3/Double-Blind), across 438 payments, paid by Allergan Inc..
- Paid by
- Allergan Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $168,572 | 438 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Thomas Weiss San Antonio, TX Named on 12 payments
- Bernardo Ng Imperial, CA Named on 12 payments
- Robert Riesenberg Atlanta, GA Named on 11 payments
- Kashinath Yadalam Lake Charles, LA Named on 11 payments
- Ashraf Attalla Smyrna, GA Named on 10 payments
- Samantha Bostrom Clinton, UT Named on 10 payments
- Adelaide Robb Washington, DC Named on 10 payments
- Judith Joseph Paterson, NJ Named on 10 payments
- Alain Katic Bellaire, TX Named on 10 payments
- Phillip Bowman Phoenix, AZ Named on 10 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.